Hepatitis B Vaccination and the Risk of Multiple SclerosisAlberto Ascherio, Alexander M. Walker, Kimberly G. Brodovicz et al.|New England Journal of Medicine|2001Cited by 432
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventoryPaul Coplan, Michael N. Oxman, Gary R. Johnson et al.|Journal of Pain|2004Cited by 304
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trialsT. Christopher Mast, John W. Shiver, Lisa Kierstead et al.|Vaccine|2009Cited by 276